Bio-Reference Laboratories Inc $28.15

down 0.00


19/9/2014 04:00 PM  |  NASDAQ : BRLI  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get BRLI Trend Analysis - it has underperformed the S&P 500 by 19%

Partner Headlines

  1. Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  2. Why I Like These Two Health Care Stocks

    GuruFocus
  3. Earnings Scheduled For August 27, 2014

    Benzinga
  4. LabCorp: A Leading Independent Diagnostic Laboratory

    GuruFocus
  5. Myriad Genetics Guidance Disappoints, Q4 Edges Views

    IBD
  6. Myriad Genetics' Earnings Face 'Angelina Jolie' Comps

    IBD
  7. Morning Market Movers

    Benzinga
  8. Earnings Scheduled For June 5, 2014

    Benzinga
  9. 4 Attractive Small-Cap Growth + Value Stocks You Have Never Heard Of

    GuruFocus
  10. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus
  11. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  12. Earnings Scheduled For March 4, 2014

    Benzinga
  13. Historical Short Interest Of Stocks - New Feature Announcement

    GuruFocus
  14. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD
  15. Myriad Hit By Downgrades After Reimbursement Cut

    IBD
  16. Earnings Scheduled For December 19, 2013

    Benzinga
  17. Stocks With The Highest Short Interest - New Feature Announcement

    GuruFocus
  18. UPDATE: Bank of America Lowers PT on Bio-Reference Laboratories Following ...

    Benzinga
  19. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD
  20. Alere Financial Says Bio-Reference Laboratories' Reimbursement Volatility ...

    Benzinga
  21. Bio-Reference cuts outlook

    IBD
  22. Stocks Up Slightly In Late Trade; Pegasystems Climbs

    IBD
  23. Bio-Reference Labs Slashes Guidance; Stock Plunges

    IBD
  24. Morning Market Losers

    Benzinga
  25. Earnings Scheduled For August 29, 2013

    Benzinga
  26. BioReference Reports Purchase of Edge BioSystems' Service Business, No ...

    Benzinga
  27. Myriad Genetics Falls On Downgrade, Despite Q4 Beat

    IBD
  28. Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  29. Bio-Reference Labs Offers Extremely Stable Earnings

    IBD
  30. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  31. Quest Diagnostics Overhaul Continues With Unit Sale

    IBD
  32. BioReference Laboratories Inc. Reports Operating Results (10-K)

    GuruFocus
  33. Bio-Reference Labs, Inc. (BRLI) Sr. VP, Sec'y, Treasurer, CFO Sam Singer ...

    GuruFocus
  34. Buffett-Munger Model Portfolio Posts Fourth Solid Year, Hits Refresh for ...

    GuruFocus
  35. Bio-Reference meets on Sandy

    IBD
  36. Stocks Mixed As Rally Fades; Lululemon Bounces Back

    IBD
  37. Bio-Reference Earnings Meet Views Despite Hurricane

    IBD
  38. Earnings Scheduled For December 6, 2012

    Benzinga
  39. Buffett-Munger Strategy: What Worked? What Didn't

    GuruFocus
  40. Many Stocks Dip In Weak Trade Amid Market Correction

    IBD
  41. Bio-Reference Laboratories Inc Reports Operating Results (10-Q)

    GuruFocus
  42. Buffett-Munger Model Portfolio Gained 16.1% Year-to-Date

    GuruFocus
  43. Stocks Back Off, So Does Volume

    IBD
  44. Health Care Sector Wrap

    FoxBusiness
  45. Stocks Trim Losses After Sliding Further

    IBD
  46. Bio-Reference Shares Fall On Q3 Revenue Shortfall

    IBD
  47. Stocks Trim Losses After Sliding Further

    IBD
  48. First Solar, Sears Holdings Among Stocks Down on Above-average Volume Thursday

    FoxBusiness
  49. US Stock Futures Down; Jobless Claims Data In Focus

    Benzinga
  50. Earnings Scheduled For August 30, 2012

    Benzinga
Trading Center